Categories AlphaGraphs, Earnings, LATEST, Other Industries
Shares fall as Pfizer misses revenue expectations
Drug giant Pfizer Inc. (PFE) posted a 1% improvement in revenues of $12.9 billion for the first quarter of 2018. Reported net income jumped 14% to $3.5 billion, while adjusted net income grew 11% to $4.6 billion. Pfizer’s shares fell more than 2% in premarket trade following the release of the results.
Reported EPS rose 15% to $0.59, while adjusted EPS grew 12% to $0.77 compared to last year. While revenue fell short of Wall Street expectations, net income for the quarter topped the consensus.
During the quarter, Pfizer returned $8.1 billion to shareholders through dividends and share repurchases.
For the full year of 2018, Pfizer expects revenues of $53.5 billion to $55.5 billion and adjusted EPS of $2.90 to $3.00.
![Pfizer Inc. Q1 2018 Earnings Infographic Pfizer Q1 2018 Earnings](https://cdn.news.alphastreet.com/wp-content/uploads/2018/05/Pfizer-Q1-2018-Earnings-Infographic-608x1024.png)
Pfizer’s quarterly results benefited from strength in anchor brands, primarily Ibrance, Eliquis, and Xeljanz. Revenues in the Innovative Health segment increased 6% to $7.8 billion while in the Essential Health segment, revenues dropped 5% to $5 billion.
The Essential Health business was negatively impacted by legacy Hospira product supply shortages in the US as well as product losses of exclusivity.
In April 2018, Pfizer announced that Trumenba received Breakthrough Therapy designation from the FDA for active immunization to prevent invasive disease caused by Neisseria meningitidis group B (MenB) in children aged one to nine. This is the first ‘Breakthrough Therapy’ designation for a MenB vaccine to help protect children as young as one year of age.
Most Popular
CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q2 2024 financial results
Colgate-Palmolive Company (NYSE: CL) reported its second quarter 2024 earnings results today. Net sales increased 4.9% year-over-year to $5 billion. Organic sales increased 9%. Net income attributable to Colgate-Palmolive Company was $731
Key takeaways from Visa’s Q3 2024 earnings report
Credit card behemoth Visa, Inc. (NYSE: V) this week reported mixed results for the June quarter, with earnings matching expectations and sales slightly missing the view. Both numbers grew in
Southwest Airlines (LUV): A look at the airline’s performance in Q2 2024
Shares of Southwest Airlines Co. (NYSE: LUV) were up over 6% on Thursday after the company beat earnings estimates for the second quarter of 2024. The stock has gained 4%